|
Announcements
ACCUVEIN LLC. SELECTS CLINIVATION WORLDVIEW®.
Innovator in the development, manufacturing and marketing of innovative products and services for the treatment of structural heart disease selects clinivation WorldView as its most comprehensive, authoritative, and up-to-date resource for building its medical product submissions and registrations worldwide.
Natick, MA, September 17,
2009 - clinivation, Inc. announced today AccuVein LLC. has
selected the clinivation WorldView enterprise solution for On-Demand
Global Regulatory Intelligence.
“AccuVein designs, manufactures, and sells medical devices that
improve clinical care and patient comfort. We are pleased that they
have chosen clinivation WorldView for comprehensive, authoritative,
and up-to-date global regulatory intelligence,” said Richard Morroney,
R.A.C., C.Q.A., clinivation's Vice President, Global Market Clearance
Solutions.
About clinivation WorldView On-Demand Global Regulatory Intelligence
Clinivation WorldView is the medical device and diagnostic industry's most comprehensive,
authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory
Intelligence. Providing clear, step-by-step market clearance regulations, processes,
and guidance for >99% of the world markets, only clinivation WorldView delivers
tried-and-true intelligence from certified, practicing professionals with real-world
experience.
About AccuVein LLC.
AccuVein applies advanced technologies to important
health care challenges. AccuVein's lead product, the AV300, allows
practitioners to see a map of the position of peripheral veins on
the patient's skin, to help caregivers locate veins while they perform
the most common invasive medical procedure - venipuncture. Built
using AccuVein's expertise in medical device miniaturization and
user-intuitive design, the AV300 is the world's first portable,
non-contact vein illumination solution. With more than a dozen patents
filed worldwide, AccuVein demonstrates an ongoing commitment to
invest in improving patient care and patient satisfaction.
For more information about Accuvein, please visit www.accuvein.com.
About clinivation, Inc. Clinivation
is the leading provider of integrated solutions that enable global market clearance.
Guided by our singular vision - "Excellence in Market Clearance" - clinivation
accelerates the entire market clearance cycle to advance new worldwide revenue
and achieve new milestones of enterprise value. Used in over 1,000,000 product
registrations by more than 100 companies worldwide, clinivation's end-to-end technology
and services deliver on our vision by eliminating revenue traps from global market
clearance operations, increasing process velocity with on-demand regulatory intelligence,
automating clearance-driven business controls, simplifying content unification
into market clearance applications, aligning quality systems with global market
clearance priorities, streamlining clinical development with clearance-focused
trials, and enabling management with key performance indicators for continuous
improvement and effective governance. The world's leading medical device,
diagnostics, hospital supply, and dental supply companies select clinivation because
of our medtech industry focus and our unique, integrated solutions that seamlessly
adapt to existing business processes and enterprise infrastructure- without the
need to write custom code. Our core brands include the clinivation Global xi
market clearance platform, clinivation WorldView on-demand regulatory intelligence,
and clinivation Clinical Suite and clinivation Registry Suite electronic data
capture and clinical data management software. Founded in 1999, the company
is headquartered in Natick, Massachusetts, with regional offices in North America
and Asia. Visit clinivation online at www.clinivation.com For
further information: For more information on clinivation's
integrated solutions that enable global market clearance, please click
here or call us at 508.655.6560. | 
